Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,730 across all filing types
Latest filing 2025-11-12 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
114年第3季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a detailed consolidated cash flow statement for the third quarter of the fiscal year 114 (which corresponds to 2025 in the Gregorian calendar). It includes comprehensive financial data such as cash flows from operating, investing, and financing activities, with specific amounts and accounting items. The presence of actual financial statements and substantive financial data for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 3045 characters, which is sufficient to contain detailed financial data rather than just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2025
2025-11-12 Chinese
114年第3季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement with detailed financial figures for the third quarter and year-to-date periods of the fiscal year 114 (Taiwan calendar year, corresponding to 2025). It includes revenue, costs, expenses, operating profit, net profit, and earnings per share data. The presence of actual financial data and detailed accounting items indicates this is a financial report for a period shorter than a full fiscal year, specifically a quarterly report. The document length is 3601 characters, which is relatively short but contains substantive financial data, so it is not merely an announcement or certification. Therefore, the document is best classified as an Interim / Quarterly Report (IR). 9M 2025
2025-11-12 Chinese
114年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items with amounts and percentages. The presence of actual financial statements and substantive financial data for a quarterly period (third quarter of year 114 in the Taiwanese calendar, corresponding to 2025 Q3) indicates this is a comprehensive interim financial report. The document length is 4415 characters, which is sufficient to contain detailed financial data rather than just an announcement or summary. There is no indication that this is an annual report, audit report, or other types of filings. Therefore, the document is best classified as an Interim / Quarterly Report (IR). Q3 2025
2025-11-12 Chinese
本公司受邀參加摩根士丹利證券舉辦之英文線上法人座談會
Regulatory Filings Classification · 90% confidence The document is a brief announcement about the company (1795 美時) participating in an online investor conference hosted by Morgan Stanley Securities. It mentions the date and time of the event and that the company will discuss its Q3 financial and operational status. The document does not contain actual financial statements or detailed financial analysis, but rather serves as a notification of the event. It is not a full financial report, earnings release, or transcript, but an announcement of an investor presentation event. Given the short length (659 characters) and the nature of the content, this fits best as an Investor Presentation (IP) announcement rather than the presentation itself. However, since it is announcing the event and not providing the presentation materials, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a general regulatory announcement about the event without substantive financial data or presentation content.
2025-11-12 Chinese
本公司受邀參加凱基證券舉辦之中文線上法人座談會
Investor Presentation Classification · 95% confidence The document is a brief announcement about the company (1795 美時) participating in an online investor conference hosted by KGI Securities. It specifies the date and time of the event and mentions that the company will discuss its Q3 financial and operational status. The document does not contain actual financial statements or detailed financial analysis but rather informs about the upcoming investor presentation event. This fits the definition of an Investor Presentation (IP) announcement rather than a full report or transcript. The document length is short and focused on the event details, consistent with an Investor Presentation notice.
2025-11-12 Chinese
公告本公司董事會決議辦理限制員工權利新股收 回註銷減資事宜
Share Issue/Capital Change Classification · 100% confidence The document is a company announcement regarding a board resolution to cancel and reduce capital due to the recall of restricted employee shares. It includes details such as the date of the board meeting, amount of capital reduction, number of shares canceled, and other related information. There is no indication of a full financial report, audit, or earnings release. The content is about a capital change event specifically related to share cancellation and capital reduction. This fits the category of Share Issue/Capital Change (SHA). The document length is short and it is a direct announcement, not a report publication or certification.
2025-11-12 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.